FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074725 [Registered on: 04/10/2024] Trial Registered Prospectively
Last Modified On: 27/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Treatment]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical Trial To Study The Effect Of Lashuna Rasayana And Vruddhadaru Rasayana In Patients With Inter Vertebral Disc Prolapse.  
Scientific Title of Study   A Randomised Comparative Clinical Study To Evaluate The Effect Of Lashuna [Allium sativum linn.] And Vruddhadaru [Argyreia speciosa sweet.] Rasayana In Gridhrasi W.S.R. To Inter Vertebral Disc Prolapse.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Akhila K S  
Designation  M. D Scholar (Kayachikitsa)  
Affiliation  Rajiv Gandhi University Of Health Sciences, Bengaluru 
Address  OPD 7,Department Of Kayachikitsa,Shri Dharmasthala Manjunatheshwara College Of Ayurveda, Hospital and Research centre,Kuthpady Udupi Udupi KARNATAKA 574118 India

Udupi
KARNATAKA
574118
India 
Phone  9497461175  
Fax    
Email  akhilaksktkl@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shrilatha Kamath T 
Designation  B.A.M.S. M.D (AYU) PhD, Professor and HOD Department of Kayachikitsa and Manasa Roga 
Affiliation  Shri Dharmasthala Manjunatheshwara College Of Ayurveda, Hospital And Research Centre, Kuthpady,Udupi 
Address  OPD 7,Department Of Kayachikitsa,Shri Dharmasthala Manjunatheshwara College Of Ayurveda,Hospital and Research centre,Kuthpady,Udupi Udupi KARNATAKA 574118 India

Udupi
KARNATAKA
574118
India 
Phone  9964899638  
Fax    
Email  shri9503@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shrilatha Kamath T 
Designation  B.A.M.S. M.D (AYU) PhD, Professor and HOD Department of Kayachikitsa and Manasa Roga 
Affiliation  Shri Dharmasthala Manjunatheshwara College Of Ayurveda, Hospital And Research Centre, Kuthpady,Udupi 
Address  OPD 7,Department Of Kayachikitsa,Shri Dharmasthala Manjunatheshwara College Of Ayurveda,Hospital and Research centre,Kuthpady,Udupi Udupi KARNATAKA 574118 India

Udupi
KARNATAKA
574118
India 
Phone  9964899638  
Fax    
Email  shri9503@gmail.com  
 
Source of Monetary or Material Support  
Shri Dharmasthala Manjunatheshwara Ayurveda Pharmacy,Laxminarayana Nagar P.O. Kuthpady-574118 Udupi,Karnataka,India 
 
Primary Sponsor  
Name  NIL 
Address  NIL 
Type of Sponsor  Other [NIL] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akhila K S   Shri Dharmasthala Manjunatheshwara Ayurveda Hospital, Kuthpady, Udupi  OPD 7,Department Of Kayachikitsa,Shri Dharmathala Manjunatheshwara College Of Ayurveda And Hospital,Kuthpady Udupi Udupi KARNATAKA 574118 India
Udupi
KARNATAKA 
09497461175

akhilaksktkl@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Clearance Committee Human  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M958||Other specified acquired deformities of musculoskeletal system. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Vruddhadaru Rasayana, Reference: Bhavaprakasa Nigandu, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 10000(mg), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: -milk), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Lashuna Rasayana , Reference: Ashtanga Hrudaya, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 10000(mg), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: -milk), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients fulfilling the diagnostic measures.
Patients between the age groups of 18-70 years.
Patients with radiological evidence of Inter vertebral disc prolapse in MRI.
Subjects who are willing to sign the informed consent form to participate in the research.

 
 
ExclusionCriteria 
Details  Patients with radiological evidence of fracture of vertebrae, congenital deformities, neoplastic conditions of the spine, infections of the spine, cervical inter vertebral disc prolapse, spondylolisthesis and ankylosing spondylitis.
Any other systemic diseases which will interfere the treatment.
People who are contraindicated for intake of Lashuna.
Pregnancy and lactating mother.
Had participated in any clinical trial within 3 months of screening.
 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changed in the signs and symptoms of Gridhrasi.
Changes in Sugar baker & Barofsky Clinical Mobility Scale and Oswestry Disability assessment questionnaire score.
Objective
SLR Test
Neurological deficit
 
0 day
17 days
45 days  
 
Secondary Outcome  
Outcome  TimePoints 
Objective
SLR Test
Neurological deficit assessed ny Herron and Turners rating. 
0 day
17 days
45 days  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a Randomised, open label, parallel group study comparing the safety and efficacy of Lashuna rasayana [group A] 10000 mg daily and the Vruddhadaru Rasayana [group B] 10000 mg daily for 15 days for 15 patients in each group and will be conducted in Shri Dharmasthala Manjunatheshwara college of Ayurveda, Hospital and Research centre, Kuthpady, Udupi, Karnataka, India. The primary measures will be assessed through Sugar baker and barofsky clinical mobility scale and Oswestry disability assessment questionnaire and secondary measures assessed through SLR test, and Herron and Turners rating. Hence, this clinical study has planned an effort to prove the efficacy of Lashuna Rasayana and Vruddhadaru Rasayana as effective against Gridrasi W.S.R. to Inter vertebral disc prolapse. 


 

 
Close